Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.

We report the discovery of the pyrimido-diazepine scaffolds as novel adenine mimics. Structure-based design led to the discovery of analogs with potent inhibitory activity against receptor tyrosine kinases, such as KDR, Flt3 and c-Kit. Compound 14 exhibited low nanomolar KDR enzymatic and cellular potencies (IC(50)=9 and 52 nM, respectively).

[1]  S. Davidsen,et al.  1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors. , 2006, Bioorganic & Medicinal Chemistry Letters.

[2]  H. Gelderblom,et al.  Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent Developments , 2007, Annals of Surgical Oncology.

[3]  K. Glaser,et al.  Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors. , 2005, Journal of medicinal chemistry.

[4]  M. Malumbres,et al.  Targeting cell cycle kinases for cancer therapy. , 2007, Current medicinal chemistry.

[5]  Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases. , 2006, Bioorganic & medicinal chemistry letters.

[6]  J. R. Huth,et al.  Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[7]  P. Richardson,et al.  Pseudosubstrate peptides inhibit Akt and induce cell growth inhibition. , 2004, Biochemistry.

[8]  K. Glaser,et al.  Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. , 2007, Journal of medicinal chemistry.

[9]  S. Schenone,et al.  Antiangiogenic agents: an update on small molecule VEGFR inhibitors. , 2007, Current medicinal chemistry.

[10]  Jeffrey Jie-Lou Liao,et al.  Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. , 2007, Journal of medicinal chemistry.